UPDATE: JMP Securities Downgrades Enanta Pharmaceuticals (ENTA) to Market Perform Citing Caution on Competitive Profile of EDP-305
Tweet Send to a Friend
(Updated - November 22, 2019 5:15 AM EST)
(update comment)JMP Securities analyst Liisa Bayko downgraded Enanta Pharmaceuticals (NASDAQ: ENTA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(update comment)JMP Securities analyst Liisa Bayko downgraded Enanta Pharmaceuticals (NASDAQ: ENTA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
